1Estruch R, Martinez-Gonzalez MA, Corella D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1–11.
2Serra-Majem L, Roman B & Estruch R (2006) Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 64, S27–S47.
3Servili M & Montedoro G (2002) Contribution of phenolic compounds to virgin olive oil quality. Eur J Lipid Sci Tech 104, 602–613.
4Visioli F, Bellomo G, Montedoro G & Galli C (1995) Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 117, 25–32.
5Caruso D, Berra B, Giavarini F, Cortesi N, Fedeli E & Galli G (1999) Effect of virgin olive oil phenolic compounds on in vitro oxidation of human low density lipoproteins. Nutr Metab Cardiovasc Dis 9, 102–107.
6Andrikopoulos NK, Kaliora AC, Assimopoulou AN & Papageorgiou VP (2002) Inhibitory activity of minor polyphenolic and non polyphenolic constituents of olive oil against in vitro low-density lipoprotein oxidation. J Med Food 5, 1–7.
7Benkhalti F, Legssyer A, Gomez P, Paz E, Lopez-Miranda J, Perez-Jimenez F & el Boustani ES (2003) Effects of virgin olive oil phenolic compounds on LDL oxidation and vasorelaxation activity. Therapie 58, 133–137.
8Ferroni F, Maccaglia A, Pietraforte D, Turco L & Minetti M (2004) Phenolic antioxidants and the protection of low density lipoprotein from peroxynitrite-mediated oxidations at physiologic CO2. J Agric Food Chem 52, 2866–2874.
9Visioli F, Bellosta S & Galli C (1998) Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages. Life Sci 62, 541–546.
10Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A & De Caterina R (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23, 622–629.
11Dell'Agli M, Fagnani R, Mitro N, et al. (2006) Minor components of olive oil modulate proatherogenic adhesion molecules involved in endothelial activation. J Agric Food Chem 54, 3259–3264.
12Petroni A, Blasevich M, Salami M, Papini N, Montedoro GF & Galli C (1995) Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb Res 78, 151–160.
13Turner R, Etienne N, Alonso MG, de Pascual-Teresa S, Minihane AM, Weinberg PD & Rimbach G (2005) Antioxidant and anti-atherogenic activities of olive oil phenolics. Int J Vitam Nutr Res 75, 61–70.
14Haslam RJ, Dickinson NT & Jang EK (1999) Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 82, 412–423.
15Bender AT & Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58, 488–520.
16Natella F, Nardini M, Virgili F & Scaccini C (2006) Role of dietary polyphenols in the platelet aggregation network - a review of the in vitro studies. Curr Topics Nutr Res 4, 1–21.
17Limiroli RC, Ottolina G, Marsilio V, Bianchi G & Zetta L (1995) 13C NMR characterisation of new oleuropein aglycons. J Chem Soc Perkin Trans 1, 1519–1523.
18Montedoro GS, Baldioli M & Miniati E (1992) Simple and hydrolizable phenolic compounds in virgin olive oil. 1. Their extraction, separation, quantitative and semiquantitative evaluation by HPLC. J Agric Food Chem 40, 1571–1576.
19Folin O & Ciocalteu V (1927) On tyrosine and tryptophane determinations in proteins. J Biol Chem 73, 627–650.
20Cardoso SM, Guyot S, Marnet N, Lopes-da-Silva JA, Renard CMGC & Coimbra MA (2005) Characterization of phenolic extracts from olive pulp and olive pomace by electrospray mass spectrometry. J Sci Food Agric 85, 21–32.
21Visioli F, Caruso D, Galli C, Viappiani S, Galli G & Sala A (2000) Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem Biophys Res Commun 278, 797–799.
22Giovanazzi S, Accomazzo MR, Letari O, Oliva D & Nicosia S (1997) Internalization and down-regulation of the prostacyclin receptor in human platelets. Biochem J 325, 71–77.
23Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.
24Kincaid RL & Manganiello VC (1988) Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates. Methods Enzymol 159, 457–470.
25Lin CS, Lau A, Tu R & Lue TF (2000) Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum. Biochem Biophys Res Commun 268, 628–635.
26Dell'Agli M, Galli GV, Vrhovsek U, Mattivi F & Bosisio E (2005) In vitro inhibition of human cGMP-specific phosphodiesterase-5 by polyphenols from red grapes. J Agric Food Chem 53, 1960–1965.
27Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G & Caruso D (2000) Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett 468, 159–160.
28Miro-Casas E, Covas MI, Farre M, Fito M, Ortuno J, Weinbrenner T, Roset P & de la Torre R (2003) Hydroxytyrosol disposition in humans. Clin Chem 49, 945–952.
29Visioli F & Galli C (2002) Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr 42, 209–221.
30Vissers MN, Zock PL & Katan MB (2004) Bioavailability and antioxidant effects of olive oil phenols in humans: a review. Eur J Clin Nutr 58, 955–965.
31Togna GI, Togna AR, Franconi M, Marra C & Guiso M (2003) Olive oil isochromans inhibit human platelet reactivity. J Nutr 133, 2532–2536.
32Bonanome A, Pagnan A, Caruso D, Toia A, Xamin A, Fedeli E, Berra B, Zamburlini A, Ursini F & Galli G (2000) Evidence of postprandial absorption of olive oil phenols in humans. Nutr Metab Cardiovasc Dis 10, 111–120.
33Miro-Casas E, Covas MI, Fito M, Farre-Albadalejo M, Marrugat J & de la Torre R (2003) Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans. Eur J Clin Nutr 57, 186–190.
34Scalbert A & Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, S2073–S2085.
35Visioli F, Galli C, Grande S, Colonnelli K, Patelli C, Galli G & Caruso D (2003) Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J Nutr 133, 2612–2615.